{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:52:16Z","timestamp":1762458736132},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1097\/mcg.0b013e31819e8bbd","type":"journal-article","created":{"date-parts":[[2009,9,18]],"date-time":"2009-09-18T12:00:23Z","timestamp":1253275223000},"page":"858-864","source":"Crossref","is-referenced-by-count":32,"title":["Hepatobiliary Abnormalities and Disease in Cystic Fibrosis"],"prefix":"10.1097","volume":"43","author":[{"given":"Sidharth","family":"Bhardwaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Canlas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Kahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M'Hamed","family":"Temkit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Molleston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ober","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Howenstine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul Y.","family":"Kwo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20210305","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005176-199900001-00001","article-title":"Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic fibrosis foundation hepatobiliary disease consensus group","volume":"28","author":"Sokol","year":"1999","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R2-12-20210305","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1055\/s-2001-19030","article-title":"Cholangiocyte biology and cystic fibrosis liver disease","volume":"21","author":"Feranchak","year":"2001","journal-title":"Semin Liver Dis"},{"key":"R3-12-20210305","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0002-9440(10)61117-0","article-title":"The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease","volume":"160","author":"Lewindon","year":"2002","journal-title":"Am J Pathol"},{"key":"R4-12-20210305","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(89)92035-7","article-title":"Liver disease and bile duct abnormalities in adults with cystic fibrosis. (see comment)","volume":"2","author":"Nagel","year":"1989","journal-title":"Lancet"},{"key":"R5-12-20210305","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00005176-198212000-00005","article-title":"Hepatobiliary disease in cystic fibrosis: a survey of current issues and concepts","volume":"1","author":"Roy","year":"1982","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R6-12-20210305","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/oxfordjournals.bmb.a072583","article-title":"Liver and biliary problems in cystic fibrosis","volume":"48","author":"Williams","year":"1992","journal-title":"Br Med Bull"},{"key":"R7-12-20210305","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11894-004-0013-6","article-title":"Hepatobiliary complications of cystic fibrosis","volume":"6","author":"Feranchak","year":"2004","journal-title":"Curr Gastroenterol Rep"},{"key":"R8-12-20210305","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.1840360613","article-title":"Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome. (see comment)","volume":"36","author":"Colombo","year":"2002","journal-title":"Hepatology"},{"key":"R9-12-20210305","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jhep.2004.08.006","article-title":"Epidemiology of liver disease in cystic fibrosis: a longitudinal study","volume":"41","author":"Lamireau","year":"2004","journal-title":"J Hepatol"},{"key":"R10-12-20210305","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jpeds.2004.05.051","article-title":"Cystic fibrosis-associated liver disease: a population-based study","volume":"145","author":"Corbett","year":"2004","journal-title":"J Pediatr"},{"key":"R11-12-20210305","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1378\/chest.118.1.80","article-title":"Cystic fibrosis: end-stage care in Canada","volume":"118","author":"Mitchell","year":"2000","journal-title":"Chest"},{"key":"R12-12-20210305","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00063198-200111000-00014","article-title":"Liver transplantation in cystic fibrosis","volume":"7","author":"Genyk","year":"2001","journal-title":"Curr Opin Pulm Med"},{"key":"R13-12-20210305","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1067\/S0022-3476(03)00329-9","article-title":"Surveillance for cystic fibrosis-associated hepatobiliary disease: early ultrasound changes and predisposing factors","volume":"143","author":"Lenaerts","year":"2003","journal-title":"J Pediatr"},{"key":"R14-12-20210305","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0140-6736(90)90647-N","article-title":"Liver disease and biliary tract abnormalities in cystic fibrosis. (comment)","volume":"335","author":"Bilton","year":"1990","journal-title":"Lancet"},{"key":"R15-12-20210305","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0022-3476(94)70361-2","article-title":"Analysis of risk factors for the development of liver disease associated with cystic fibrosis. (see comment)","volume":"124","author":"Colombo","year":"1994","journal-title":"J Pediatr"},{"key":"R16-12-20210305","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1055\/s-2007-1007316","article-title":"Hepatobiliary disease in cystic fibrosis","volume":"14","author":"Colombo","year":"1994","journal-title":"Semin Liver Dis"},{"key":"R17-12-20210305","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1399-0004.1992.tb03254.x","article-title":"Deletion delta F508 and clinical expression of cystic fibrosis-related liver disease","volume":"42","author":"De Arce","year":"1992","journal-title":"Clin Genet"},{"key":"R18-12-20210305","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.510300527","article-title":"Natural history of liver disease in cystic fibrosis","volume":"30","author":"Lindblad","year":"1999","journal-title":"Hepatology"},{"key":"R19-12-20210305","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0140-6736(81)90422-0","article-title":"Hepatic complications of cystic fibrosis","volume":"2","author":"Psacharopoulos","year":"1981","journal-title":"Lancet"},{"key":"R20-12-20210305","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1053\/jhep.2003.50403","article-title":"Risk factors for the development of cystic fibrosis related liver disease. (comment)","volume":"38","author":"Slieker","year":"2003","journal-title":"Hepatology"},{"key":"R21-12-20210305","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00005176-200104000-00005","article-title":"Markers of cystic fibrosis-associated liver disease. (comment)","volume":"32","author":"Narkewicz","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R22-12-20210305","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1440-1754.1998.00241.x","article-title":"The use of human glutathione S-transferase A1 in the detection of cystic fibrosis liver disease","volume":"34","author":"Hung","year":"1998","journal-title":"J Paediatr Child Health"},{"key":"R23-12-20210305","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/clinchem\/35.9.1888","article-title":"High-molecular-mass (\u201cbiliary\u201d) isoenzyme of alkaline phosphatase and the diagnosis of liver dysfunction in cystic fibrosis","volume":"35","author":"Schoenau","year":"1989","journal-title":"Clin Chem"},{"key":"R24-12-20210305","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/crad.2001.0861","article-title":"Ultrasound evaluation of liver disease in cystic fibrosis as part of an annual assessment clinic: a 9-year review","volume":"57","author":"Williams","year":"2002","journal-title":"Clin Radiol"},{"key":"R25-12-20210305","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1542\/peds.103.1.52","article-title":"Clinical and genetic risk factors for cystic fibrosis-related liver disease","volume":"103","author":"Wilschanski","year":"1999","journal-title":"Pediatrics"},{"key":"R26-12-20210305","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bpg.2005.11.006","article-title":"Cystic fibrosis: nutritional consequences and management","volume":"20","author":"Dodge","year":"2006","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R27-12-20210305","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.200403-404OC","article-title":"Late diagnosis defines a unique population of long-term survivors of cystic fibrosis","volume":"171","author":"Rodman","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R28-12-20210305","doi-asserted-by":"crossref","first-page":"359","DOI":"10.12968\/bjon.2003.12.6.11243","article-title":"Management of cystic fibrosis-related diabetes in adolescence","volume":"12","author":"Azzopardi","year":"2003","journal-title":"Br J Nurs"},{"key":"R29-12-20210305","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/01.mcp.0000245708.59138.a4","article-title":"Update on maintaining bone health in cystic fibrosis","volume":"12","author":"Boyle","year":"2006","journal-title":"Curr Opin Pulm Med"},{"key":"R30-12-20210305","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1210\/jc.2004-1629","article-title":"Guide to bone health and disease in cystic fibrosis","volume":"90","author":"Aris","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R31-12-20210305","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1378\/chest.118.2.427","article-title":"Health status and sociodemographic characteristics of adults receiving a cystic fibrosis diagnosis after age 18 years","volume":"118","author":"Widerman","year":"2000","journal-title":"Chest"},{"key":"R32-12-20210305","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0025-7753(02)73513-6","article-title":"Cystic fibrosis in adults: study of 111 patients","volume":"119","author":"de Gracia","year":"2002","journal-title":"Med Clin"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004836-200910000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:23:14Z","timestamp":1618035794000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004836-200910000-00012"}},"subtitle":["Epidemiology and Outcomes Through Adulthood"],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0b013e31819e8bbd","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}